These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32517741)

  • 21. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial.
    Boonyawat K; Wang L; Lazo-Langner A; Kovacs MJ; Yeo E; Schnurr T; Schulman S; Crowther MA
    Thromb Haemost; 2016 Aug; 116(3):480-5. PubMed ID: 27346552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective Comparison of Point-of-Care Device and Standard Analyzer for Monitoring of International Normalized Ratio in Outpatient Oral Anticoagulant Clinic.
    Moiz B; Rashid A; Hasan M; Jafri L; Raheem A
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1153-1158. PubMed ID: 29374969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Warfarin Dosages and International Normalized Ratios Before and After Roux-en-Y Gastric Bypass Surgery.
    Steffen KJ; Wonderlich JA; Erickson AL; Strawsell H; Mitchell JE; Crosby RD
    Pharmacotherapy; 2015 Sep; 35(9):876-80. PubMed ID: 26406775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin.
    Marusic S; Gojo-Tomic N; Bacic-Vrca V; Franic M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):431-3. PubMed ID: 22677303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
    Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
    Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between hormone replacement therapy preparations and oral anticoagulant therapy.
    McLintock LA; Dykes A; Tait RC; Walker ID
    BJOG; 2003 Aug; 110(8):777-9. PubMed ID: 12892692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low dose oral anticoagulation therapy in Chinese children with congenital heart disease.
    Cheung YF; Leung MP
    J Paediatr Child Health; 1998 Dec; 34(6):563-7. PubMed ID: 9928651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral anticoagulants. Pharmacologic issues for use in the elderly.
    Hylek EM
    Clin Geriatr Med; 2001 Feb; 17(1):1-13. PubMed ID: 11270124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Xa and anti-IIa drugs alter international normalized ratio measurements: potential problems in the monitoring of oral anticoagulants.
    Tobu M; Iqbal O; Hoppensteadt D; Neville B; Messmore HL; Fareed J
    Clin Appl Thromb Hemost; 2004 Oct; 10(4):301-9. PubMed ID: 15497016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study].
    Alonso Roca R; Figueroa Guerrero CA; Mainar de Paz V; Arribas García MP; Sánchez Perruca L; Rodríguez Barrientos R; Casado López M; Pedraza Flechas AM
    Med Clin (Barc); 2015 Sep; 145(5):192-7. PubMed ID: 25433789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing.
    Løkkegaard T; Pedersen TH; Lind B; Siersma V; Waldorff FB
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
    Oertel LB
    Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management and dosing of warfarin therapy.
    Gage BF; Fihn SD; White RH
    Am J Med; 2000 Oct; 109(6):481-8. PubMed ID: 11042238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature.
    Andrus MR
    Pharmacotherapy; 2004 Feb; 24(2):285-90. PubMed ID: 14998226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.